Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Doubling Outcomes by Lung Cancer Early Diagnosis: An Observational, Study to Collect Real-world Evidence (RWE) on the Management of Pulmonary Nodules Across Latin-America

NCT05091437 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05091437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05091437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Doubling Outcomes by Lung Cancer Early Diagnosis: An Observational, Study to Collect Real-world Evidence (RWE) on the Management of Pulmonary Nodules Across Latin-America
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 30, 2021
Completion date
November 30, 2024
Enrollment
562 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary nodules